AstraZeneca's Enhertu Wins China Reimbursement
AstraZeneca's Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that ...
AstraZeneca Plc’s recent share-price rout has gone so far that the pharma stock has shaken off the last of its bearish ...
We recently published a list of 12 Best ADR Stocks To Invest In According to Analysts. In this article, we are going to take ...
AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...
AstraZeneca Pharmaceuticals LP violated federal and Ohio law when it denied a Christian sales specialist an exemption from ...
Truqap’s positive clinical data comes after it failed a late-stage study in metastatic triple-negative breast cancer. It ...
Dr. Bob Li, a top Asian leader from the New York-based Memorial Sloan Kettering Cancer Center, has become global head of ...
Current global health developments include China's green light for foreign-owned hospitals, the addition of AstraZeneca's ...
Analyst Andrew Berens from Leerink Partners maintained a Buy rating on AstraZeneca (AZN – Research Report) and keeping the price target at ...
Researchers review the safety, efficacy, and considerations for COVID-19 vaccination in multiple sclerosis patients, ...
The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback